Search Results - "ROUAS, Ghislane"

Multifactorial Approach to Predicting Resistance to Anthracyclines by DESMEDT, Christine, DI LEO, Angelo, MAEREVOET, Marie, VINDEVOGHEL, Anita, ROUAS, Ghislane, LALLEMAND, Françoise, DURBECQ, Virginie, CARDOSO, Fatima, SALGADO, Roberto, ROVERE, Rodrigo, BONTEMPI, Gianluca, MICHIELS, Stefan, DE AZAMBUJA, Evandro, BUYSE, Marc, NOGARET, Jean-Marie, YUAN QI, SYMMANS, Fraser, PUSZTAI, Lajos, D'HONDT, Véronique, PICCART-GEBHART, Martine, SOTIRIOU, Christos, LARSIMONT, Denis, HAIBE-KAINS, Benjamin, SELLESLAGS, Jean, DELALOGE, Suzette, DUHEM, Caroline, KAINS, Jean-Pierre, CARLY, Birgit

“…Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP)…”
Get full text

Tumor‐infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome by Lespagnard, Laurence, Gancberg, David, Rouas, Ghislane, Leclercq, Guy, de Saint‐Aubain Somerhausen, Nicolas, Di Leo, Angelo, Piccart, Martine, Verhest, Alain, Larsimont, Denis

“…Dendritic cells (DC) are the most potent antigen‐presenting cells, and induce antigen‐specific immune responses. Infiltration of tumors by DC is thought to…”
Get full text

Farnesoid X receptor in primary breast carcinoma: A new marker to predict bone metastasis? by Journe, Fabrice, Durbecq, Virginie, Chaboteaux, Carole, Rouas, Ghislane, IdBoufker, Hichame, Laurent, Guy, Larsimont, Denis, Body, Jean-Jacques

Get full text

OC3. Farnesoid X receptor (FXR): A new marker for the prediction of bone metastases in breast cancer by Journe, Fabrice, Durbecq, Virginie, Chaboteaux, Carole, Rouas, Ghislane, Haibe-Kains, Benjamin, IdBoufker, Hichame, Laurent, Guy, Sotiriou, Christos, Larsimont, Denis, Body, Jean-Jacques

Get full text